|
Biological processes
|
|
GO:0009987
|
Cellular process
|
1186
|
0.03
|
1.1E−04
|
|
GO:0065007
|
Biological regulation
|
979
|
0.04
|
1.1E−04
|
|
GO:0050789
|
Regulation of biological process
|
942
|
0.05
|
2.92E−05
|
|
GO:0050794
|
Regulation of cellular process
|
896
|
0.05
|
2.88E−05
|
|
GO:0008152
|
Metabolic process
|
818
|
0.05
|
1.1E−04
|
|
Cell component
|
|
GO:0005623
|
Cell
|
1312
|
0.03
|
1.39E−07
|
|
GO:0005622
|
Intracellular
|
1225
|
0.06
|
7.97E−16
|
|
GO:0043226
|
Organelle
|
1062
|
0.05
|
5.67E−09
|
|
GO:0043229
|
Intracellular organelle
|
1042
|
0.05
|
1.28E−08
|
|
GO:0005737
|
Cytoplasm
|
993
|
0.07
|
1.68E−11
|
|
Molecular function
|
|
GO:0005488
|
Binding
|
1006
|
0.05
|
3.75E−06
|
|
GO:0005515
|
Protein binding
|
614
|
0.09
|
1.33E−06
|
|
GO:0043167
|
Ion binding
|
541
|
0.07
|
1.1E−03
|
|
GO:0003824
|
Catalytic activity
|
499
|
0.07
|
2.6E−03
|
|
GO:0097159
|
Organic cyclic compound binding
|
464
|
0.06
|
3.41E−02
|
|
KEGG pathways
|
|
hsa04310
|
Wnt signaling pathway
|
32
|
0.47
|
1.1E−04
|
|
hsa04390
|
Hippo signaling pathway
|
30
|
0.42
|
7.5E−04
|
|
hsa04550
|
Signaling pathways regulating pluripotency of stem cells
|
28
|
0.43
|
7.5E−04
|
|
hsa04261
|
Adrenergic signaling in cardiomyocytes
|
27
|
0.41
|
3.7E−03
|
|
hsa05200
|
Pathways in cancer
|
67
|
0.24
|
3.7E−03
|
|
Reactome pathways
|
|
HSA-3238698
|
WNT ligand biogenesis and trafficking
|
11
|
0.75
|
2.23E−02
|
|
HSA-198725
|
Nuclear events (kinase and transcription factor activation)
|
9
|
0.68
|
4.12E−02
|
|
HSA-450282
|
MAPK targets/ nuclear events mediated by MAP kinases
|
10
|
0.63
|
4.12E−02
|
|
HSA-8986944
|
Transcriptional regulation by MECP2
|
16
|
0.56
|
2.23E−02
|
|
HSA-187037
|
Signaling by NTRK1 (TRKA)
|
18
|
0.5
|
2.23E−02
|
